Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antivirals.
Fukumoto T, Minami T, Moriyama M, Yamada T, Wake T, Kinoshita MN, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Enooku K, Nakagawa H, Fujishiro M, Shiina S, Koike K, Tateishi R.
Fukumoto T, et al.
Hepatol Commun. 2022 Sep;6(9):2496-2512. doi: 10.1002/hep4.2010. Epub 2022 May 31.
Hepatol Commun. 2022.
PMID: 35641233
Free PMC article.
This study aimed to evaluate the prognosis of C-HCC in the DAA era. We enrolled 1237 consecutive patients with treatment-naive C-HCC who underwent radical radiofrequency ablation between 1999 and 2019. ...
This study aimed to evaluate the prognosis of C-HCC in the DAA era. We enrolled 1237 consecutive patients with treatment-naive C-HCC …